Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1983 | 2334 | 50.2 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CAVEOLIN 1 | Author keyword | 330 | 50% | 21% | 482 |
2 | CAVEOLAE | Author keyword | 259 | 44% | 19% | 445 |
3 | CAVEOLIN | Author keyword | 213 | 49% | 13% | 315 |
4 | CAVEOLIN 3 | Author keyword | 70 | 60% | 3% | 76 |
5 | RIPPLING MUSCLE DISEASE | Author keyword | 62 | 92% | 1% | 24 |
6 | CAVEOLIN 2 | Author keyword | 36 | 77% | 1% | 24 |
7 | PTRF | Author keyword | 35 | 89% | 1% | 16 |
8 | CAVIN 1 | Author keyword | 21 | 85% | 0% | 11 |
9 | CAV 1 | Author keyword | 19 | 63% | 1% | 19 |
10 | CAVEOLINS | Author keyword | 19 | 61% | 1% | 20 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CAVEOLIN 1 | 330 | 50% | 21% | 482 | Search CAVEOLIN+1 | Search CAVEOLIN+1 |
2 | CAVEOLAE | 259 | 44% | 19% | 445 | Search CAVEOLAE | Search CAVEOLAE |
3 | CAVEOLIN | 213 | 49% | 13% | 315 | Search CAVEOLIN | Search CAVEOLIN |
4 | CAVEOLIN 3 | 70 | 60% | 3% | 76 | Search CAVEOLIN+3 | Search CAVEOLIN+3 |
5 | RIPPLING MUSCLE DISEASE | 62 | 92% | 1% | 24 | Search RIPPLING+MUSCLE+DISEASE | Search RIPPLING+MUSCLE+DISEASE |
6 | CAVEOLIN 2 | 36 | 77% | 1% | 24 | Search CAVEOLIN+2 | Search CAVEOLIN+2 |
7 | PTRF | 35 | 89% | 1% | 16 | Search PTRF | Search PTRF |
8 | CAVIN 1 | 21 | 85% | 0% | 11 | Search CAVIN+1 | Search CAVIN+1 |
9 | CAV 1 | 19 | 63% | 1% | 19 | Search CAV+1 | Search CAV+1 |
10 | CAVEOLINS | 19 | 61% | 1% | 20 | Search CAVEOLINS | Search CAVEOLINS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONCOGENICALLY TRANSFORMED CELLS | 258 | 81% | 7% | 156 |
2 | SCAFFOLDING DOMAIN | 256 | 82% | 6% | 148 |
3 | D7S522 LOCUS 7Q311 | 128 | 94% | 2% | 46 |
4 | P42 44 MAP KINASE | 70 | 82% | 2% | 41 |
5 | VIP21 CAVEOLIN | 69 | 91% | 1% | 29 |
6 | RICH MEMBRANE DOMAINS | 56 | 56% | 3% | 68 |
7 | SURVIVAL CLONAL GROWTH | 56 | 85% | 1% | 29 |
8 | SHOW EVIDENCE | 50 | 73% | 2% | 38 |
9 | PROTEIN COMPONENT | 46 | 47% | 3% | 72 |
10 | TRANSCRIPT RELEASE FACTOR | 45 | 66% | 2% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Caveolae as plasma membrane sensors, protectors and organizers | 2013 | 115 | 200 | 69% |
The multiple faces of caveolae | 2007 | 606 | 135 | 72% |
Interaction of membrane/lipid rafts with the cytoskeleton: Impact on signaling and function Membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling | 2014 | 39 | 205 | 32% |
Exploring the caves: cavins, caveolins and caveolae | 2010 | 120 | 131 | 69% |
Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation | 2010 | 97 | 101 | 80% |
Caveolae as organizers of pharmacologically relevant signal transduction molecules | 2008 | 184 | 190 | 73% |
Caveolin-1 in oncogenic transformation, cancer, and metastasis | 2005 | 277 | 128 | 80% |
Role of caveolae and caveolins in health and disease | 2004 | 464 | 270 | 58% |
Caveolin-1 in tumor progression: the good, the bad and the ugly | 2008 | 122 | 258 | 82% |
Caveolin-1, galectin-3 and lipid raft domains in cancer cell signalling | 2015 | 1 | 48 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HORMONE DEPENDENT TUMOR BIOL | 14 | 50% | 0.9% | 20 |
2 | SERV MALATTIE NEUROMUSCOLARI | 13 | 69% | 0.5% | 11 |
3 | ALBERT E EIN CANC | 8 | 13% | 2.4% | 56 |
4 | INTEGRIN SIGNALING | 5 | 40% | 0.4% | 10 |
5 | LUNG VASC BIOL | 5 | 17% | 1.2% | 27 |
6 | RU NEURAL REGENERAT | 4 | 75% | 0.1% | 3 |
7 | UCL FATH 5349 | 4 | 75% | 0.1% | 3 |
8 | G GASLINI PEDIAT | 3 | 100% | 0.1% | 3 |
9 | MUSCULAR NEURODEGENERAT DIS UNIT | 3 | 15% | 0.8% | 19 |
10 | PROGRAM VASC CELL SIGNALING THER EUT | 3 | 38% | 0.3% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000131639 | VASCULAR ENDOTHELIAL DYSFUNCTION//MOL CARDIOBIOL PROGRAM//VASCULAR ENDOTHELIUM DYSFUNCTION |
2 | 0.0000071729 | STOMATIN//PSEUDOHYPERKALAEMIA//REGGIE |
3 | 0.0000061375 | FENOVERINE//IDIOPATHIC HYPER CK EMIA//HYPERCKEMIA |
4 | 0.0000048373 | ENDOTHELIAL GLYCOCALYX//GLYCOCALYX//ENDOTHELIAL SURFACE LAYER |
5 | 0.0000043724 | LIQUID ORDERED PHASE//LIQUID ORDERED//CHOLESTATRIENOL |
6 | 0.0000042996 | BOVINE HIPPOCAMPUS//SEROTONIN1A RECEPTOR//P MPPF |
7 | 0.0000035827 | DYNAMIN//F BAR DOMAIN//AMPHIPHYSIN |
8 | 0.0000033720 | POLYOMAVIRUS VP1//SV40 VECTORS//SECT VIROL ONCOL |
9 | 0.0000032140 | MARGARET DYSON VIS//APICAL SORTING//BASOLATERAL SORTING |
10 | 0.0000032133 | JEFFERSON STEM CELL BIOL REGENERAT MED//CANCER ASSOCIATED FIBROBLASTS//CANCER ASSOCIATED FIBROBLAST |